Apimeds Pharmaceuticals US, Inc.

# Apimeds Pharmaceuticals US, Inc.

The company operates in digital asset treasury solutions, with a focus on bitcoin treasury infrastructure. Based in Ras al-Khaimah, United Arab Emirates, Apimeds Pharmaceuticals US, Inc. is incorporated in Delaware and trades on the NYSE. Despite its name and pharmaceutical sector classification, the company's stated business activities center on digital asset management rather than traditional pharmaceutical manufacturing or drug development.

The company's primary business involves providing infrastructure and solutions related to bitcoin and digital asset treasury management. This represents a departure from the pharmaceutical industry classification under which the company is categorized, suggesting either a business pivot or a mismatch between current operations and historical sector designation.

Limited public information is available regarding the company's employee count, annual revenue, or geographic operational footprint beyond its headquarters location in the UAE. The company's market capitalization is reported at $0.0 billion, indicating either minimal market valuation or recent listing status.